Literature DB >> 16405930

Reduced angiogenic responses in adult Endoglin heterozygous mice.

Mirjana Jerkic1, Alicia Rodríguez-Barbero, Marta Prieto, Mourad Toporsian, Miguel Pericacho, Juan V Rivas-Elena, Juana Obreo, Angela Wang, Fernando Pérez-Barriocanal, Miguel Arévalo, Carmelo Bernabéu, Michelle Letarte, José M López-Novoa.   

Abstract

OBJECTIVE: To determine if angiogenesis is altered in adult Endoglin heterozygous (Eng(+/-)) mice, the animal model for the vascular disorder hereditary hemorrhagic telangiectasia type 1 (HHT1).
METHODS: Primary cultures of endothelial cells were generated from Eng(+/-) and Eng(+/+) mice and analyzed for proliferation, migration, and ability to form capillary-like tubes. Endothelial cells derived from umbilical veins of newborns (HUVEC) with an HHT1 genotype were also tested for capillary formation. Two in vivo models of angiogenesis were tested in the Eng(+/-) and Eng(+/+) mice: Matrigel implant-dependent angiogenesis and reperfusion following hindlimb ischemia.
RESULTS: The Eng(+/-) endothelial cells displayed significantly reduced proliferation and migration, increased collagen production, and decreased NO synthase expression and vascular endothelial growth factor (VEGF) secretion. They also showed impaired capillary tube formation in vitro, as did the HHT1 HUVEC. These endothelial cell-specific abnormalities were associated with impaired Matrigel-dependent capillary tube formation in vivo and delayed reperfusion following hindlimb ischemia.
CONCLUSIONS: Although vascular development is normal in Eng(+/-) mice, angiogenic abnormalities were observed in the adult mice and their isolated endothelial cells. These results suggest that a normal level of endoglin is required for full angiogenic activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16405930     DOI: 10.1016/j.cardiores.2005.11.020

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  34 in total

1.  Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation.

Authors:  Melania E Mercado-Pimentel; Antony D Hubbard; Raymond B Runyan
Journal:  Dev Biol       Date:  2006-12-23       Impact factor: 3.582

2.  Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth.

Authors:  Roselyne Castonguay; Eric D Werner; Robert G Matthews; Eleonora Presman; Aaron W Mulivor; Nicolas Solban; Dianne Sako; R Scott Pearsall; Kathryn W Underwood; Jasbir Seehra; Ravindra Kumar; Asya V Grinberg
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

3.  Cell adhesion molecules and eNOS expression in aorta of normocholesterolemic mice with different predispositions to atherosclerosis.

Authors:  Jana Rathouska; Ivana Nemeckova; Lenka Zemankova; Zbynek Strasky; Katerina Jezkova; Michala Varejckova; Petr Nachtigal
Journal:  Heart Vessels       Date:  2014-03-15       Impact factor: 2.037

4.  Choroidal and retinal thickening in severe preeclampsia.

Authors:  Aakriti Garg; Ronald J Wapner; Cande V Ananth; Elizabeth Dale; Stephen H Tsang; Winston Lee; Rando Allikmets; Srilaxmi Bearelly
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-29       Impact factor: 4.799

Review 5.  Endoglin in liver fibrogenesis: Bridging basic science and clinical practice.

Authors:  Steffen K Meurer; Muhammad Alsamman; David Scholten; Ralf Weiskirchen
Journal:  World J Biol Chem       Date:  2014-05-26

6.  Endoglin regulates the activation and quiescence of endothelium by participating in canonical and non-canonical TGF-β signaling pathways.

Authors:  Sunyoung Park; Terri A Dimaio; Wei Liu; Shoujian Wang; Christine M Sorenson; Nader Sheibani
Journal:  J Cell Sci       Date:  2013-02-15       Impact factor: 5.285

7.  Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis.

Authors:  Young-Chan Kwon; Reina Sasaki; Keith Meyer; Ranjit Ray
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

8.  VEGF Induces More Severe Cerebrovascular Dysplasia in Endoglin than in Alk1 Mice.

Authors:  Qi Hao; Yiqian Zhu; Hua Su; Fanxia Shen; Guo-Yuan Yang; Helen Kim; William L Young
Journal:  Transl Stroke Res       Date:  2010-09-01       Impact factor: 6.829

9.  Endoglin deficiency impairs stroke recovery.

Authors:  Fanxia Shen; Vincent Degos; Pei-Lun Chu; Zhenying Han; Erick M Westbroek; Eun-Jung Choi; Douglas Marchuk; Helen Kim; Michael T Lawton; Mervyn Maze; William L Young; Hua Su
Journal:  Stroke       Date:  2014-05-29       Impact factor: 7.914

10.  Impaired wound repair in adult endoglin heterozygous mice associated with lower NO bioavailability.

Authors:  Eduardo Pérez-Gómez; Mirjana Jerkic; Marta Prieto; Gaelle Del Castillo; Ester Martín-Villar; Michelle Letarte; Carmelo Bernabeu; Fernando Pérez-Barriocanal; Miguel Quintanilla; José M López-Novoa
Journal:  J Invest Dermatol       Date:  2013-06-13       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.